Accelerating Energy-Efficient Atmospheric Carbon Capture Technologies
AirInMotion aims to demonstrate and commercialize a modular CO2 capture technology for industrial applications, enabling significant emissions reductions and supporting a circular carbon economy.
Projectdetails
Introduction
The IPCC and the EU recognize the importance of CO2 removal from the atmosphere to achieve their climate-neutrality objectives and limit global warming to 1.5C. AirInMotion provides an efficient and sustainable technology that captures CO2 from air.
Technology Overview
It operates independently of location as stand-alone units or integrated in industrial processes utilizing low-grade heat. It uses state-of-the-art adsorbents that are abundant, cheap, and non-toxic, which are regenerated during continuous capture and release cycles.
Modular Design
The technology is modular, whereby larger capture plants are composed of multiple synchronized units that use central auxiliary components. Industrial integration facilitates CO2 capture at scale and results in high-quality CO2 that can be used as a feedstock for the production of valuable products in a circular carbon economy.
Industry Impact
AirInMotion offers an opportunity to address industries whose indirect emissions in the supply chain cannot be removed at source, achieving significant emission reductions through remediation where this was not previously possible or has not been addressed by regulation or policy requirements.
Global Adoption
Its characteristics enable AirInMotion to be globally adoptable, supporting Europe and the wider global societies to meet their carbon emission targets.
Project Objectives
This project will focus on three objectives:
- The demonstration of the effectiveness of the AirInMotion technology at scale through the construction of industrial prototypes reaching TRL-6.
- The validation of the technology through the deployment of demonstrators in selected industries, including airports, the food industry, and IT data centers. Further deployment will demonstrate a fully circular system using low-grade heat to provide research-grade CO2, which is in-situ used as refrigerant.
- The development of commercialization and business strategies for a new spin-out company that will progress the economic, technological, and societal impacts of the technology in the future.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.494.251 |
Totale projectbegroting | € 2.494.251 |
Tijdlijn
Startdatum | 1-1-2024 |
Einddatum | 31-12-2026 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- THE PROVOST, FELLOWS, FOUNDATION SCHOLARS & THE OTHER MEMBERS OF BOARD, OF THE COLLEGE OF THE HOLY & UNDIVIDED TRINITY OF QUEEN ELIZABETH NEAR DUBLINpenvoerder
Land(en)
Vergelijkbare projecten binnen EIC Transition
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Targeting cardiac fibrosis with next generation RNA therapeuticsFIBREX aims to develop an innovative ncRNA-based antisense oligonucleotide therapy targeting Meg3 to reverse cardiac fibrosis and treat heart failure, advancing towards clinical readiness. | EIC Transition | € 2.499.482 | 2022 | Details |
automated in-line separatioN and dEtection of eXtracellular vesicles for liqUid biopsy applicationSThe NEXUS project aims to industrialize a customizable platform for the separation and analysis of extracellular vesicles from biofluids, enhancing cancer diagnostics and monitoring. | EIC Transition | € 2.497.750 | 2022 | Details |
Predictive REagent-Antibody Replacement Technology stage 2-TranslationPRe-ART-2T aims to advance predictive antibody technology to TRL6, replacing low-quality monoclonal antibodies with high-performing synthetic alternatives, and attract ~€20M in investment. | EIC Transition | € 800.000 | 2022 | Details |
Advancing a vaccine targeting genetic amyotrophic lateral sclerosis (C9orf72 ALS) to the clinical stageDeveloping a poly-GA peptide vaccine to reduce protein aggregation and motor deficits in C9orf72 ALS, aiming for clinical evaluation and market entry through strategic partnerships. | EIC Transition | € 2.499.810 | 2022 | Details |
Targeting cardiac fibrosis with next generation RNA therapeutics
FIBREX aims to develop an innovative ncRNA-based antisense oligonucleotide therapy targeting Meg3 to reverse cardiac fibrosis and treat heart failure, advancing towards clinical readiness.
automated in-line separatioN and dEtection of eXtracellular vesicles for liqUid biopsy applicationS
The NEXUS project aims to industrialize a customizable platform for the separation and analysis of extracellular vesicles from biofluids, enhancing cancer diagnostics and monitoring.
Predictive REagent-Antibody Replacement Technology stage 2-Translation
PRe-ART-2T aims to advance predictive antibody technology to TRL6, replacing low-quality monoclonal antibodies with high-performing synthetic alternatives, and attract ~€20M in investment.
Advancing a vaccine targeting genetic amyotrophic lateral sclerosis (C9orf72 ALS) to the clinical stage
Developing a poly-GA peptide vaccine to reduce protein aggregation and motor deficits in C9orf72 ALS, aiming for clinical evaluation and market entry through strategic partnerships.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
CFC Pilot for CCSThe CFCPILOT4CCS project aims to pilot Carbonate Fuel Cells for CO2 capture from industrial streams in Rotterdam, targeting 46,000 tonnes of greenhouse gas avoidance and enhancing technology for wider application. | InnovFund LSC | € 30.497.000 | 2023 | Details |
Direct Air Capture for on-site CO2 utilization in greenhousesCARBOMINER's C-DAC technology captures atmospheric CO2 using a cost-effective, electric process to provide low-cost, fossil-free CO2 for industries like greenhouses and fertilizers. | EIC Accelerator | € 1.548.268 | 2024 | Details |
Decentralised Direct Air Capture The most sustainable, affordable and scalable way to produce clean CO2 on demandSkytree develops modular, small-scale carbon capture solutions to produce clean CO2 for sustainable greenhouse farming, reducing reliance on fossil fuels and enhancing crop yields. | EIC Accelerator | € 2.481.587 | 2024 | Details |
Carbon Atlantis Project to Undo Residual Emissions - construction and deployment of a minimum viable product the Gen3 stack capable of capturing 500 tonnes CO2 per year from the air.Carbon Atlantis aims to finalize and deploy a cost-effective electrolyser for CO2 capture, targeting 500,000t/year by 2030 and 100 megatonnes/year by 2045 to achieve carbon neutrality. | EIC Accelerator | € 2.494.672 | 2024 | Details |
CFC Pilot for CCS
The CFCPILOT4CCS project aims to pilot Carbonate Fuel Cells for CO2 capture from industrial streams in Rotterdam, targeting 46,000 tonnes of greenhouse gas avoidance and enhancing technology for wider application.
Direct Air Capture for on-site CO2 utilization in greenhouses
CARBOMINER's C-DAC technology captures atmospheric CO2 using a cost-effective, electric process to provide low-cost, fossil-free CO2 for industries like greenhouses and fertilizers.
Decentralised Direct Air Capture The most sustainable, affordable and scalable way to produce clean CO2 on demand
Skytree develops modular, small-scale carbon capture solutions to produce clean CO2 for sustainable greenhouse farming, reducing reliance on fossil fuels and enhancing crop yields.
Carbon Atlantis Project to Undo Residual Emissions - construction and deployment of a minimum viable product the Gen3 stack capable of capturing 500 tonnes CO2 per year from the air.
Carbon Atlantis aims to finalize and deploy a cost-effective electrolyser for CO2 capture, targeting 500,000t/year by 2030 and 100 megatonnes/year by 2045 to achieve carbon neutrality.